Epizyme To Present At 2015 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today announced its participation at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, 2015 at 1:55 p.m. ET at the Le Parker Meridien Hotel in New York.

Help employers find you! Check out all the jobs and post your resume.

Back to news